Miljenko V. Pilepich

10.1k total citations · 4 hit papers
111 papers, 7.6k citations indexed

About

Miljenko V. Pilepich is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Radiation. According to data from OpenAlex, Miljenko V. Pilepich has authored 111 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Pulmonary and Respiratory Medicine, 30 papers in Surgery and 26 papers in Radiation. Recurrent topics in Miljenko V. Pilepich's work include Prostate Cancer Diagnosis and Treatment (69 papers), Prostate Cancer Treatment and Research (64 papers) and Advanced Radiotherapy Techniques (26 papers). Miljenko V. Pilepich is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (69 papers), Prostate Cancer Treatment and Research (64 papers) and Advanced Radiotherapy Techniques (26 papers). Miljenko V. Pilepich collaborates with scholars based in United States, Canada and Puerto Rico. Miljenko V. Pilepich's co-authors include David J. Grignon, Sucha O. Asbell, C.A. Lawton, Gerald E. Hanks, William T. Sause, Kathryn Winter, William U. Shipley, John M. Krall, J Mesić and Kyounghwa Bae and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Cancer.

In The Last Decade

Miljenko V. Pilepich

110 papers receiving 7.3k citations

Hit Papers

Androgen suppression adju... 1997 2026 2006 2016 2005 2001 1997 2008 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miljenko V. Pilepich United States 47 6.3k 1.9k 1.6k 1.2k 966 111 7.6k
Thomas M. Pisansky United States 51 7.2k 1.1× 2.8k 1.4× 2.3k 1.5× 1.8k 1.5× 861 0.9× 215 9.8k
C.A. Lawton United States 34 5.2k 0.8× 2.1k 1.1× 831 0.5× 680 0.6× 566 0.6× 132 6.2k
Kathryn Winter United States 52 5.5k 0.9× 2.7k 1.4× 4.0k 2.5× 2.6k 2.2× 340 0.4× 163 10.3k
C.A. Lawton United States 31 3.3k 0.5× 1.8k 0.9× 494 0.3× 470 0.4× 350 0.4× 83 4.4k
Gert De Meerleer Belgium 35 4.4k 0.7× 1.9k 1.0× 839 0.5× 724 0.6× 412 0.4× 168 5.5k
Marisa Kollmeier United States 38 3.6k 0.6× 2.0k 1.0× 800 0.5× 416 0.3× 409 0.4× 156 4.6k
D.A. Loblaw Canada 29 2.5k 0.4× 877 0.5× 643 0.4× 587 0.5× 185 0.2× 88 3.4k
Valérie Fonteyne Belgium 31 3.3k 0.5× 1.3k 0.7× 790 0.5× 579 0.5× 363 0.4× 132 4.2k
Himu Lukka Canada 24 2.0k 0.3× 1.2k 0.6× 1.1k 0.7× 1.1k 0.9× 180 0.2× 77 4.4k
Alberto Bossi France 28 1.8k 0.3× 527 0.3× 556 0.3× 487 0.4× 275 0.3× 106 2.6k

Countries citing papers authored by Miljenko V. Pilepich

Since Specialization
Citations

This map shows the geographic impact of Miljenko V. Pilepich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miljenko V. Pilepich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miljenko V. Pilepich more than expected).

Fields of papers citing papers by Miljenko V. Pilepich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miljenko V. Pilepich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miljenko V. Pilepich. The network helps show where Miljenko V. Pilepich may publish in the future.

Co-authorship network of co-authors of Miljenko V. Pilepich

This figure shows the co-authorship network connecting the top 25 collaborators of Miljenko V. Pilepich. A scholar is included among the top collaborators of Miljenko V. Pilepich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miljenko V. Pilepich. Miljenko V. Pilepich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Souhami, Luís, Kyounghwa Bae, Miljenko V. Pilepich, & Howard M. Sandler. (2010). Timing of Salvage Hormonal Therapy in Prostate Cancer Patients With Unfavorable Prognosis Treated With Radiotherapy: A Secondary Analysis of Radiation Therapy Oncology Group 85-31. International Journal of Radiation Oncology*Biology*Physics. 78(5). 1301–1306. 22 indexed citations
2.
Smith, Matthew R., Kyounghwa Bae, Jason A. Efstathiou, et al.. (2008). Diabetes and Mortality in Men With Locally Advanced Prostate Cancer: RTOG 92-02. Journal of Clinical Oncology. 26(26). 4333–4339. 47 indexed citations
3.
Khor, Li‐Yan, Kyounghwa Bae, Tahseen Al‐Saleem, et al.. (2008). Protein Kinase A RI-α Predicts for Prostate Cancer Outcome: Analysis of Radiation Therapy Oncology Group Trial 86-10. International Journal of Radiation Oncology*Biology*Physics. 71(5). 1309–1315. 27 indexed citations
4.
Roach, Mack, Kyounghwa Bae, Joycelyn L. Speight, et al.. (2008). Short-Term Neoadjuvant Androgen Deprivation Therapy and External-Beam Radiotherapy for Locally Advanced Prostate Cancer: Long-Term Results of RTOG 8610. Journal of Clinical Oncology. 26(4). 585–591. 451 indexed citations breakdown →
5.
Efstathiou, Jason A., Kyounghwa Bae, William U. Shipley, et al.. (2008). Cardiovascular Mortality After Androgen Deprivation Therapy for Locally Advanced Prostate Cancer: RTOG 85-31. Journal of Clinical Oncology. 27(1). 92–99. 179 indexed citations
7.
Pilepich, Miljenko V., Kathryn Winter, C.A. Lawton, et al.. (2005). Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma—long-term results of phase III RTOG 85–31. International Journal of Radiation Oncology*Biology*Physics. 61(5). 1285–1290. 665 indexed citations breakdown →
8.
Pilepich, Miljenko V., Richard Caplan, Roger W. Byhardt, et al.. (1997). Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31.. Journal of Clinical Oncology. 15(3). 1013–1021. 492 indexed citations breakdown →
9.
10.
Pilepich, Miljenko V., Jan W. Buzydlowski, Madhu J. John, et al.. (1995). Phase II trial of hormonal cytoreduction with megestrol and diethylstilbestrol in conjunction with radiotherapy for carcinoma of the prostate: Outcome results of RTOG 83-07. International Journal of Radiation Oncology*Biology*Physics. 32(1). 175–180. 24 indexed citations
11.
Hanks, Gerald E., Sucha O. Asbell, John M. Krall, et al.. (1991). Outcome for lymph node dissection negative T-1b, T-2 (A-2,B) prostate cancer treated with external beam radiation therapy in RTOG 77-06. International Journal of Radiation Oncology*Biology*Physics. 21(4). 1099–1103. 71 indexed citations
12.
Myerson, Robert J., Miljenko V. Pilepich, Joseph N. Fields, et al.. (1989). Physical predictors of adequate hyperthermia with the annular phased array. International Journal of Hyperthermia. 5(6). 749–755. 4 indexed citations
13.
Pilepich, Miljenko V., Richard J. Johnson, Carlos A. Perez, et al.. (1987). Prognostic significance of nodal involvement in locally advanced (stage C) carcinoma of prostate—RTOG experience. Urology. 30(6). 535–540. 8 indexed citations
14.
Pilepich, Miljenko V., et al.. (1987). Radiation therapy in the treatment of chemodectomas. The Laryngoscope. 97(11). 1331–1335. 71 indexed citations
15.
Emami, B., et al.. (1987). Postoperative radiation therapy in the management of lung cancer.. Radiology. 164(1). 251–253. 8 indexed citations
16.
Pilepich, Miljenko V., John M. Krall, Gerald E. Hanks, et al.. (1987). Correlation of pre-treatment transurethral resection and prognosis in patients with stage C carcinoma of the prostate treated with definitive radiotherapy—rtog experience. International Journal of Radiation Oncology*Biology*Physics. 13(2). 195–199. 16 indexed citations
17.
Emami, Bahman, et al.. (1987). Malignant melanoma: analysis of dose fractionation in radiation therapy.. Radiology. 164(3). 607–610. 46 indexed citations
18.
Pilepich, Miljenko V., Thomas F. Pajak, Sucha O. Asbell, et al.. (1983). Preliminary report on phase III RTOG studies of extended-field irradiation in carcinoma of the prostate. American Journal of Clinical Oncology. 6(4). 485–492. 15 indexed citations
19.
Pilepich, Miljenko V., Carlos A. Perez, Bruce J. Walz, & Fred Zivnuska. (1981). Complications of definitive radiotherapy for carcinoma of the prostate. International Journal of Radiation Oncology*Biology*Physics. 7(10). 1341–1348. 85 indexed citations
20.
Pilepich, Miljenko V., Carlos A. Perez, Bruce J. Walz, & Fred Zivnuska. (1980). Complications of definitive radiotherapy for carcinoma of the prostate. International Journal of Radiation Oncology*Biology*Physics. 6(10). 1421–1422. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026